Addition of venetoclax to myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in high-risk AML.
Cao XY, Chen JQ, Wang H, Ma W, Liu WW, Zhang FF, Xue S, Dong L, Liu T, Zhao XZ, Liu CC, Xu X, He Y, Wang L, Wang JL.
Cao XY, et al. Among authors: wang h, wang l, wang jl.
Ann Med. 2023 Dec;55(1):388-400. doi: 10.1080/07853890.2022.2164610.
Ann Med. 2023.
PMID: 36629738
Free PMC article.